CLINICAL_TRIALS
trial_result
· 2017-03-13
Clinical Trial Update: Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Summary
This document reports results from a Phase 2 trial of infusional carfilzomib in patients with relapsed or refractory multiple myeloma. The study, conducted at M…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-13